Novant Health to acquire three hospitals from Tenet Healthcare

Go back to Novant Health to acquire three hospitals from Tenet Healthcare

Goldman Sachs Reiterates Buy Rating on Tenet Healthcare (THC) as Hospital Sales 'Highlight Underlying Asset Values'

November 17, 2023 11:39 AM EST

Goldman Sachs analyst Jamie Perse reiterated a Buy rating and $85.00 price target on Tenet Healthcare (NYSE: THC) after the company sold three South Carolina hospitals for $2.4B with estimated after-tax proceeds of $1.75B.

The analyst commented, "The company disclosed that the network of hospitals generated approximately... More